A year later, similar results indicated that downregulation of HOTAIR might enhance the sensitivity of CML cells to imatinib through the PI3K/AKT/MRP1 pathway [34]. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.